It has been shown that the suppression of CaMKs (CAMKIV) coupled with human leukocyte immunoglobulin-like receptor B2 (LILRB2) signaling is associated with decreased human acute leukemia proliferation in vitro and in vivo [20]. This evidence concerns the gene LILRB2 and acute leukemia.